Endogenous knock-down of survival genes improves chemotherapeutic response in a T-ALL cell line

9522 Background: New targets for more effective, less toxic therapeutic approaches to childhood acute lymphoblastic leukemia (ALL) can be developed by discovering pathways unique to the blast. Usin...